Cosan (CSAN3) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
2 Jul, 2026Executive summary
Management prioritized disciplined capital allocation, liability management, and portfolio optimization amid high interest rates and economic volatility in Brazil.
Significant management changes included new CEOs for Cosan, Cosan Investimentos, and Raízen, aiming to refocus on core business and simplify operations.
Portfolio transactions included the acquisition of Compagas, sale of Norgás, acquisition of Pax Group, sale of Vista Alegre Farm, and sale of Vale shares and related derivatives.
Consolidated net sales reached R$32.2 billion for 9M24, up from R$29.96 billion in 9M23, with strong contributions from Raízen, Compass, Moove, and Rumo.
EBITDA for 9M24 was R$13.2 billion, compared to R$11.56 billion in 9M23, reflecting operational growth and margin expansion.
Financial highlights
Adjusted EBITDA under management reached R$8.2 billion in 3Q24, up 2% year-over-year.
Net income for Cosan Corporate was R$293 million, down from R$679 million in 3Q23, mainly due to lower dividends from Vale and negative impact from TRS of Cosan shares.
Dividends and interest on capital received totaled R$343 million, down from R$503 million in 3Q23.
Net debt at Cosan Corporate stood at R$21.7 billion, stable compared to Q2.
Cash balance decreased to R$2.4 billion at quarter-end due to liability management activities.
Outlook and guidance
Management expects continued growth in core segments, with ongoing investments in logistics, energy, and infrastructure, and remains focused on capital discipline and asset recycling.
No major debt amortizations are expected until 2026, supporting ongoing investment cycles.
E2G (second-generation ethanol) remains part of Raízen's core, with focus on completing plants under construction before reassessing further expansion.
Latest events from Cosan
- EBITDA and net income fell, but major asset sales and capital raises improved leverage and liquidity.CSAN3
Q4 20259 Jul 2026 - Net loss reached R$1.8B, EBITDA fell 30%, but net debt dropped to R$17.5B after asset sales.CSAN3
Q1 20258 Jul 2026 - EBITDA rose 15% to R$7.1bn, net loss narrowed, and capital discipline remained strong.CSAN3
Q2 20242 Jul 2026 - Net revenue rose 11%, but large impairments led to a R$9.4 billion net loss in 2024.CSAN3
Q4 20242 Jul 2026 - Net loss narrowed to R$1.6 billion, with strong EBITDA and major deleveraging actions.CSAN3
Q1 202622 May 2026 - EBITDA and net income declined, but R$10.5 billion equity raised improved capital structure.CSAN3
Q3 20253 Feb 2026 - EBITDA fell to R$6.0bn, net loss widened, and leverage rose to 3.4x as segment results diverged.CSAN3
Q2 20253 Feb 2026